Table 3

Effects of tamoxifen on serum lipids

StudyTotal cholesterol (mg/dl)LDL cholesterol (mg/dl)HDL cholesterol (mg/dl)TT%change
Control (no. of patients)TT3-b (no. of patients)%changeControlTT%changeControl
Rossner and Wallgren, 1984 302  (10)258  (11)−15%201156−22%8775NS
Bruning et al., 1988 220  (46)205  (46)−7%151124−18%4350NS
Bertelli et al., 1988 254  (36)213  (55)−16%180127−29%5556NS
Bagdade et al., 1990 193  (8)204  (8)NS122115−6%4549NS
Love et al., 1991 216  (70)190  (70)−12%138110−20%5753NS
Ingram, 1990 259  (47)234  (13)−9%193171−10%6661NS
Cuzick et al., 1992 256  (47)225  (14)−12%186145−22%5043−14%
Dnistrian et al., 1993 244  (13)203  (24)−17%169123−27%5556NS
Thangaraju et al., 1994 224  (45)190  (39)−15%149132−17%54587%
Average249214−13%165134−19%5752NS
  • 3-a The summation of nine studies examining the effects of tamoxifen therapy on serum lipid profiles in women (adapted fromBilimoria et al., 1996a).

  • 3-b TT, tamoxifen-treated group; NS, not statistically significant.